CARDIFF ONCOLOGY, INC. (CRDF) Operating cash flow 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$37.9MFY2025 · since FY2016: -$31.0M → -$37.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$37.9M | -0.6% |
| FY2024 | -$37.7M | -22.0% |
| FY2023 | -$30.9M | +8.7% |
| FY2022 | -$33.8M | -46.8% |
| FY2021 | -$23.0M | -41.2% |
| FY2020 | -$16.3M | -23.0% |
| FY2019 | -$13.3M | -0.5% |
| FY2018 | -$13.2M | +43.3% |
| FY2017 | -$23.3M | +25.0% |
| FY2016 | -$31.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice